Patent 8486924 was granted and assigned to Celator Pharmaceuticals on July, 2013 by the United States Patent and Trademark Office.
Nanoparticulate formulations for delivery of taxane conjugate prodrug formed from a taxane coupled to a hydrophobic moiety through a glycolate linker are described.